Clinical trial
Prospective Multicenter Pilot Study to Evaluate the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvant Chemotherapy (NeoVAB)
NCT03876951 is registered in ClinicalTrials.gov with Centre Georges Francois Leclerc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Multicenter Pilot Study to Evaluate the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvant Chemotherapy (NeoVAB)
- Lead sponsor
- Centre Georges Francois Leclerc
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 30, 2019
- Completion date
- April 8, 2025
- Enrollment
- 67 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
vacuum-assisted biopsy